Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

3.05
EUR
-0.21
(-6.43%)
-0.52EPS
703.45MMarket Cap
Feb 25Next Earn

Aclaris Therapeutics, Inc. Documents

Q1 FY2026 · Presentation

ATI-052 SAD MAD final data storyboard 042726 FINAL · 30 pages

Read Aclaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents